Elacestrant Impresses in EMERALD Trial of Breast Cancer

Promising Phase III Results in HR+/HER2- Breast Cancer

Breast landmark trials dr.kiran

Overview of the EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer

ASCO Breast Cancer Session 2021: Panel Discussion

Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial - The ASCO Post

Katherine Sanchez MD on X: Breast cancer has had so many big wins this year. Check out our review of elacestrant, the first trial reporting a pill formulation of SERD is effective

Forefront Breaking News

EMERALD Trial of Elacestrant in ER+, HER2- Advanced Breast Cancer: Efficacy and Safety Data

Elacestrant in metastatic breast cancer: Is the “standard of care” meeting standard requirements? - ScienceDirect

Experts Discuss Clinical Highlights from SABCS 2021

Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)